IKT Inhibikase Therapeutics Earnings growth forecast for next year

Corporate company logo of inhibikase.com (IKT)

Inhibikase Therapeutics faces high business instability due to its critical dependence on FDA test outcomes and the ongoing search for investment. The profit growth rate model for the coming year illustrates the market reaction, where the value is fixed at -10.60. While the company develops patent-protected c-Abl inhibitors for Parkinson's therapy, the lack of current sales limits its pricing power until drug efficacy is confirmed.

Inhibikase Therapeutics Inc (IKT): Consensus forecast of earnings per share growth for next year from 07/04/2022 to 11/18/2026

Inhibikase - analytical breakdowns and key metrics (IKT)

Fundamental valuation:Inhibikase Therapeutics, IKT
Brand item of Inhibikase Therapeutics Inc

This indicator reflects consolidated analyst forecasts for earnings per share changes next year, signaling market expectations for business growth rates. The history of forward EPS estimates for Inhibikase Therapeutics (IKT) depends directly on the success of kinase inhibitor clinical trials. Positive momentum here confirms market confidence in the commercial potential of the Parkinson's disease patents. The high volatility of this metric underscores the speculative nature of the company's assets.

Competitor analysis for Inhibikase Therapeutics

Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros) - Earnings growth forecast for next year|NGNE - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year AC Immune Corp (ACIU)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (neumoratx.com)|SCLX - Expected earnings per share growth for next year|tevogen.com - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Alpha Cognition Inc. (ACOG)|CGTX: Earnings growth forecast for next year|Expected earnings per share growth for next year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth forecast for next year|Expected earnings per share growth for next year Coya Therapeutics (COYA)|Expected earnings per share growth for next year VTGN (Vistagen)|Consensus forecast of earnings per share growth for next year Ovid Therapeutics Inc|Earnings growth forecast for next year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Expected earnings per share growth for next year|Alterity Therapeutics Limited - Earnings growth forecast for next year|Expected net earnings per share growth next year Clene Inc|PEPG: Earnings growth forecast for next year|Expected earnings per share growth for next year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth forecast for next year|Earnings growth forecast for next year Annovis Bio Corporation|Earnings growth forecast for next year GRCE|AIFF: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Klotho Neurosciences KLTO|NRSN: Projected earnings per share growth rate for next year|RVPH: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year MetaVia MTVA|neuraxis.com (NRXS) - Net earnings per share growth forecast for next year|Helius Medical Technologies Inc. - Expected earnings per share trend next year|PASG (Passage Bio, Inc.) - Earnings growth forecast for next year|bionomics.com.au - Net earnings per share change forecast for next year|Earnings growth forecast for next year NERV|ATHA (Athira) - Expected earnings per share trend next year|Addex Therapeutics - Expected earnings per share growth for next year|ALZN - Expected earnings per share growth for next year|Cyclerion Therapeutics, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Expected earnings per share growth for next year|Projected earnings per share growth rate for next year CRGT|Expected earnings per share growth for next year ATXI|Expected earnings per share growth for next year Brainstorm Cell (BCLI)|Expected earnings per share growth for next year CARA (Cara Therapeutics, Inc.)|Expected earnings per share growth for next year Chromocell Therapeutics Corp CHRO|Earnings growth forecast for next year ELYM (Eliem Therapeutics, Inc.)|Earnings growth forecast for next year intracellulartherapies.com ITCI|Longboard Pharmaceuticals - Earnings growth forecast for next year|Consensus forecast of earnings per share growth for next year Marinus Pharmaceuticals, Inc. MRNS|NKGN: Earnings growth forecast for next year|NeuroBo Pharmaceuticals Inc - Expected earnings per share trend next year|SAGE (Sage Therapeutics Inc.) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year SNPX (Neurotrope)|Net earnings per share growth forecast for next year Trevena Inc. (TRVN)|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year